Production (Stage)
Goldenwell Biotech, Inc.
GWLL
$0.20
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -100.00 | 100.00 | 100.00 | 500.00 | 700.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00 | 100.00 | 100.00 | 500.00 | 700.00 |
| Cost of Revenue | 0.00 | 0.00 | 200.00 | 400.00 | 400.00 |
| Gross Profit | 0.00 | 0.00 | -300.00 | -100.00 | -100.00 |
| SG&A Expenses | 124.50K | 121.20K | 121.50K | 134.00K | 111.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 124.50K | 121.20K | 121.70K | 134.40K | 111.70K |
| Operating Income | -124.40K | -121.10K | -121.70K | -134.00K | -111.20K |
| Income Before Tax | -134.90K | -131.60K | -125.40K | -137.70K | -114.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.13 | -0.13 | -0.13 | -0.14 | -0.11 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -134.90K | -131.60K | -125.40K | -137.70K | -114.90K |
| EBIT | -124.40K | -121.10K | -121.70K | -134.00K | -111.20K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 398.57M | 398.57M | 398.57M | 398.57M | 398.57M |
| Average Diluted Shares Outstanding | 398.57M | 398.57M | 398.57M | 398.57M | 398.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |